Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 26 Oct 2022 07:45 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Third quarter and YTD 2022 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 18 Oct 2022 14:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q3 2022 conference call | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 19 Aug 2022 07:50 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Second quarter and first half 2022 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 11 Aug 2022 13:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q2 2022 conference call | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 19 May 2022 11:50 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Minutes from the annual general meeting 2022 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Apr 2022 13:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Notice of Annual General Meeting | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Apr 2022 13:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Annual Report for 2021 | 20103015 Pharmaceuticals | Annual financial and audit Reports |
| 27 Apr 2022 07:45 CEST |
VISTIN PHARMA | Vistin Pharma ASA: First quarter 2022 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 20 Apr 2022 13:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q1 2022 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Feb 2022 07:40 CET |
VISTIN PHARMA | Vistin Pharma ASA: Fourth quarter 2021 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 16 Feb 2022 15:45 CET |
VISTIN PHARMA | New interim CEO | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Feb 2022 14:00 CET |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q4 2021 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Dec 2021 09:38 CET |
VISTIN PHARMA | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |